FC-GAMMA-RIIA POLYMORPHISM IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH INVASIVE PNEUMOCOCCAL DISEASE

Citation
J. Abadi et al., FC-GAMMA-RIIA POLYMORPHISM IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH INVASIVE PNEUMOCOCCAL DISEASE, Pediatric research, 42(3), 1997, pp. 259-262
Citations number
29
Categorie Soggetti
Pediatrics
Journal title
ISSN journal
00313998
Volume
42
Issue
3
Year of publication
1997
Pages
259 - 262
Database
ISI
SICI code
0031-3998(1997)42:3<259:FPIHIV>2.0.ZU;2-5
Abstract
Invasive pneumococcal disease (IPD) occurs frequently in HIV-infected children and adults. Defects in complement func tion, opsonic capsular antibodies, and Fc receptor antibody mediated phagocytosis could cont ribute to impaired host defense against Streptococcus pneumoniae. The objective of this study was to define the distribution of the three Fc gamma RIIa genotypes in HIV+ children, including those with IPD. Fort y-eight HIV+ Hispanic children, including eight with IPD, followed at Bronx-Lebanon Hospital Center, Bronx, New York, nine HIV+ adults with IPD, and 56 HIV- Hispanic control subjects were studied. The children and adults were identified retrospectively except for one child who de veloped TPD during the study. Fc gamma RIIa genotypes were determined by PCR amplification of the Fc gamma RIIa locus from genomic DNA sampl es and hybridization of the PCR products with allele-specific oligonuc leotides. Naturally occurring serum antibodies reactive with four pneu mococcal polysaccharide serotypes were determined by ELISA in seven of eight children with IPD. There were no statistical differences in Fc gamma RIIa genotypes between HIV+ children with and without IPD, HIVadults with IPD, or HN-Hispanics. The predominant IgG subclass of pneu mococcal polysaccharide binding antibodies in the seven HIV+ children with IPD studied was IgG,. The distribution of Fc gamma RIIa genotypes in HIV+ children with and without IPD is similar to that of the norma l Hispanic population. The prospect of passive immunotherapy with spec ific anticapsular antibodies might be a promising alternative for the treatment and/or prevention of IPD in HIV+ children and other immunode ficient groups.